Contribution of α2-adrenoceptors to the mitogenic effect of catecholestrogen in human breast cancer MCF-7 cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 110, Issue 1-2, 2008, Pages 170-175

  Chiesa, Ignacio Javier ^a   Castillo, Lilian Fedra ^a   Lüthy, Isabel Alicia ^a  

^a INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

Author keywords

2 Adrenoceptors; Breast cancer; Catecholestrogen; Human; MCF 7

Indexed keywords

2 HYDROXY ESTRADIOL; 2 HYDROXY ESTRONE; 4 HYDROXY ESTRONE; ALPHA 2 ADRENERGIC RECEPTOR; CATECHOL ESTROGEN; CLONIDINE; ESTRADIOL; FULVESTRANT; RAUWOLSCINE; YOHIMBINE; DRUG DERIVATIVE; ESTROGEN RECEPTOR;

ARTICLE; BREAST CANCER; CANCER CELL; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG ANTAGONISM; DRUG BINDING; DRUG EFFECT; HUMAN; HUMAN CELL; BREAST TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROTEIN BINDING; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; ESTRADIOL; ESTROGENS, CATECHOL; HUMANS; PROTEIN BINDING; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, ESTROGEN; YOHIMBINE;

EID: 44649179222     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2008.03.035     Document Type: Article

References (35)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 55 2 (2005) 74-108
2. Belous A.R., Hachey D.L., Dawling S., Roodi N., and Parl F.F. Cytochrome P450 1B1-mediated estrogen metabolism results in estrogen-deoxyribonucleoside adduct formation. Cancer Res. 67 2 (2007) 812-817
3. Newman S.P., Ireson C.R., Tutill H.J., Day J.M., Parsons M.F., Leese M.P., Potter B.V., Reed M.J., and Purohit A. The role of 17beta-hydroxysteroid dehydrogenases in modulating the activity of 2-methoxyestradiol in breast cancer cells. Cancer Res. 66 1 (2006) 324-330
4. Philips B.J., Ansell P.J., Newton L.G., Harada N., Honda S., Ganjam V.K., Rottinghaus G.E., Welshons W.V., and Lubahn D.B. Estrogen receptor-independent catechol estrogen binding activity: protein binding studies in wild-type, Estrogen receptor-alpha KO, and aromatase KO mice tissues. Biochemistry 43 21 (2004) 6698-6708
5. Gaikwad N.W., Yang L., Muti P., Meza J.L., Pruthi S., Ingle J.N., Rogan E.G., and Cavalieri E.L. The molecular etiology of breast cancer: evidence from biomarkers of risk. Int. J. Cancer 122 9 (2008) 1949-1957
6. Cavalieri E., Chakravarti D., Guttenplan J., Hart E., Ingle J., Jankowiak R., Muti P., Rogan E., Russo J., Santen R., and Sutter T. Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention. Biochim. Biophys. Acta 1766 1 (2006) 63-78
7. Russo J., Fernandez S.V., Russo P.A., Fernbaugh R., Sheriff F.S., Lareef H.M., Garber J., and Russo I.H. 17-Beta-estradiol induces transformation and tumorigenesis in human breast epithelial cells. FASEB J. 20 10 (2006) 1622-1634
8. Schutze N., Vollmer G., Tiemann I., Geiger M., and Knuppen R. Catecholestrogens are MCF-7 cell estrogen receptor agonists. J. Steroid Biochem. Mol. Biol. 46 6 (1993) 781-789
9. Schutze N., Vollmer G., and Knuppen R. Catecholestrogens are agonists of estrogen receptor dependent gene expression in MCF-7 cells. J. Steroid Biochem. Mol. Biol. 48 5-6 (1994) 453-461
10. Zhu B.T., and Conney A.H. Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 19 1 (1998) 1-27
11. Karkoulias G., Mastrogianni O., Papathanasopoulos P., Paris H., and Flordellis C. alpha(2)-Adrenergic receptors activate cyclic AMP-response element-binding protein through arachidonic acid metabolism and protein kinase A in a subtype-specific manner. J. Neurochem. 103 3 (2007) 882-895
12. Kable J.W., Murrin L.C., and Bylund D.B. In vivo gene modification elucidates subtype-specific functions of alpha(2)-adrenergic receptors. J. Pharmacol. Exp. Ther. 293 1 (2000) 1-7
13. Vazquez S.M., Mladovan A.G., Perez C., Bruzzone A., Baldi A., and Luthy I.A. Human breast cell lines exhibit functional alpha(2)-adrenoceptors. Cancer Chemother. Pharmacol. 58 (2006) 50-61
14. Vazquez S.M., Pignataro O., and Luthy I.A. Alpha2-adrenergic effect on human breast cancer MCF-7 cells. Breast Cancer Res. Treat. 55 1 (1999) 41-49
15. Berthois Y., Katzenellenbogen J.A., and Katzenellenbogen B.S. Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc. Natl. Acad. Sci. U.S.A. 83 8 (1986) 2496-2500
16. Shayo C., Fernandez N., Legnazzi B.L., Monczor F., Mladovan A., Baldi A., and Davio C. Histamine H2 receptor desensitization: involvement of a select array of G protein-coupled receptor kinases. Mol. Pharmacol. 60 5 (2001) 1049-1056
17. Jansson C.C., Savola J.M., and Akerman K.E. Different sensitivity of alpha 2A-C10 and alpha 2C-C4 receptor subtypes in coupling to inhibition of cAMP accumulation. Biochem. Biophys. Res. Commun. 199 2 (1994) 869-875
18. Cheng Y., and Prusoff W.H. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 22 23 (1973) 3099-3108
19. Dowdy S., and Wearden S. Statistics for Research (1983), John Wiley & Sons, Inc, New York, Chichester, Brisbane, Toronto, Singapore
20. Kimbro K.S., Duschene K., Willard M., Moore J.A., and Freeman S. A novel gene STYK1/NOK is upregulated in estrogen receptor-alpha negative estrogen receptor-beta positive breast cancer cells following estrogen treatment. Mol. Biol. Rep. 35 1 (2008) 23-27
21. Ma D., Hossain M., Rajakumaraswamy N., Arshad M., Sanders R.D., Franks N.P., and Maze M. Dexmedetomidine produces its neuroprotective effect via the alpha 2A-adrenoceptor subtype. Eur. J. Pharmacol. 502 1-2 (2004) 87-97
22. Etchegoyen G.S., Cardinali D.P., Perez A.E., Tamayo J., and Perez-Palacios G. Binding and effects of catecholestrogens on adenylate cyclase activity, and adrenoceptors, benzodiazepine and GABA receptors in guinea-pig hypothalamic membranes. Eur. J. Pharmacol. 129 1-2 (1986) 1-10
23. Vandewalle B., Revillion F., and Lefebvre J. Functional beta-adrenergic receptors in breast cancer cells. J. Cancer Res. Clin. Oncol. 116 3 (1990) 303-306
24. Slotkin T.A., Zhang J., Dancel R., Garcia S.J., Willis C., and Seidler F.J. Beta-adrenoceptor signaling and its control of cell replication in MDA-MB-231 human breast cancer cells. Breast Cancer Res. Treat. 60 2 (2000) 153-166
25. Slotkin T.A., and Seidler F.J. Antimitotic and cytotoxic effects of theophylline in MDA-MB-231 human breast cancer cells. Breast Cancer Res. Treat. 64 3 (2000) 259-267
26. Vandewalle B., Peyrat J.P., Bonneterre J., and Lefebvre J. Catecholestrogen binding sites in breast cancer. J. Steroid Biochem. 23 5A (1985) 603-610
27. Vandewalle B., Hornez L., and Lefebvre J. Characterization of catecholestrogen membrane binding sites in estrogen receptor positive and negative human breast cancer cell-lines. J. Recept. Res. 8 5 (1988) 699-712
28. Hurt C.M., Feng F.Y., and Kobilka B. Cell-type specific targeting of the alpha 2c-adrenoceptor. Evidence for the organization of receptor microdomains during neuronal differentiation of PC12 cells. J. Biol. Chem. 275 45 (2000) 35424-35431
29. Seeger H., Deuringer F.U., Wallwiener D., and Mueck A.O. Breast cancer risk during HRT: influence of estradiol metabolites on breast cancer and endothelial cell proliferation. Maturitas 49 3 (2004) 235-240
30. Gupta M., McDougal A., Safe S., and Estrogenic. antiestrogenic activities of 16alpha- and 2-hydroxy metabolites of 17beta-estradiol in MCF-7 and T47D human breast cancer cells. J. Steroid Biochem. Mol. Biol. 67 5-6 (1998) 413-419
31. Castagnetta L.A., Granata O.M., Traina A., Ravazzolo B., Amoroso M., Miele M., Bellavia V., Agostara B., and Carruba G. Tissue content of hydroxyestrogens in relation to survival of breast cancer patients. Clin. Cancer Res. 8 10 (2002) 3146-3155
32. Osipo C., Liu H., Meeke K., and Jordan V.C. The consequences of exhaustive antiestrogen therapy in breast cancer: estrogen-induced tumor cell death. Exp. Biol. Med. (Maywood) 229 8 (2004) 722-731
33. Hodges-Gallagher L., Valentine C.D., Bader S.E., and Kushner P.J. Estrogen receptor beta increases the efficacy of antiestrogens by effects on apoptosis and cell cycling in breast cancer cells. Breast Cancer Res. Treat. 109 (2008) 241-250
34. Stender J.D., Frasor J., Komm B., Chang K.C., Kraus W.L., and Katzenellenbogen B.S. Estrogen regulated gene networks in human breast cancer cells: involvement of E2F1 in the regulation of cell proliferation. Mol. Endocrinol. 21 9 (2007) 2112-2123
35. Lin C.Y., Strom A., Li K.S., Kietz S., Thomsen J.S., Tee J.B., Vega V.B., Miller L.D., Smeds J., Bergh J., Gustafsson J.A., and Liu E.T. Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer. Breast Cancer Res. 9 2 (2007) R25